arrow
D

Doug A. Brooks

College of Health
H指数:53
被引数:9,097

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tuning the lipophilicity of a 3,4-dialkoxy-1,8-naphthalimide scaffold to optimise live cell lipid droplet imaging

通过调节3,4-二烷氧基-1,8-萘二甲酰亚胺骨架的脂溶性以优化活细胞脂滴成像

2026-10-010
OAAI
Androgen drives early endosome vesicular trafficking machinery expression to alter Appl1 endosome and leptin signaling in prostate cancer

雄激素驱动早期内体囊泡转运机制的表达,以改变前列腺癌中Appl1内体和瘦素信号通路

2026-09-090
OA
Crosstalk Between Inflammasome Signalling and Epithelial-Mesenchymal Transition in Cancer and Benign Disease: Mechanistic Insights, Context-Dependence, and Therapeutic Opportunities

炎症小体信号与上皮-间质转化在癌症和良性疾病中的串扰:机制洞察、情境依赖性和治疗机遇

Cells
IF5.2
2026-03-030
OAAI
Circulating tumour cells are a prognostic indicator in advanced high-grade serous ovarian cancer and are associated with platelets and immune cells following dissemination

循环肿瘤细胞是晚期高级别浆液性卵巢癌的预后指标,且在播散后与血小板和免疫细胞相关联。

2025-10-100
OA
Metabolic reprogramming, malignant transformation and metastasis: Lessons from chronic lymphocytic leukaemia and prostate cancer

代谢重编程、恶性转化和转移:从慢性淋巴细胞白血病和前列腺癌中得到的启示

2025-02-010
PRE
Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinoma
2024-11-010
OA
Altered expression of vesicular trafficking machinery in prostate cancer affects lysosomal dynamics and provides insight into the underlying biology and disease progression
2024-08-312
OA
Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system
2024-03-013
OAAI
Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread
2023-10-018
OAAI